Vertos Medical Secures $26 Million To Expand Commercialization Efforts And Develop Breakthrough Treatments For Chronic Low Back Pain
Jun 07, 2023•about 2 years ago
Amount Raised
$26 Million
Investors
Pitango Venture CapitalNorwest Venture Partners
Description
Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), announced today that it has raised $26 million in an oversubscribed Series C equity funding round. The financing was led by new investor Norwest Venture Partners with participation from existing investors including Pitango Venture Capital.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech